Neuralink
Neuralink raises $600M Series at $9B valuation
Quick Facts
Neuralink: Series Funding Round
Neuralink has successfully raised $600M in Series funding, reaching a valuation of $9B.
Company Overview
Brain-computer interface company developing brain implants
Funding Details
The Series round was led by Valor Equity Partners, with participation from Craft Ventures.
Company Information
- Headquarters: Fremont, CA
- Founded: 2016
- Employees: 400+
- Category: HealthTech
Investment
Neuralink plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Valor Equity Partners: Verified investor in Series
- Craft Ventures: Verified investor in Series
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
